Body mass index, chronic atrophic gastritis and heartburn: A population-based study among 8936 older adults from Germany

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 2, 2010, Pages 296-302

  Gao, L ^a,b   Weck, M N ^a   Rothenbacher, D ^a   Brenner, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BODY MASS; CHRONIC GASTRITIS; FEMALE; GASTROESOPHAGEAL REFLUX; GERMANY; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT;

AGED; BODY MASS INDEX; CHRONIC DISEASE; COHORT STUDIES; FEMALE; GASTRIC ACID; GASTRITIS, ATROPHIC; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MIDDLE AGED; OBESITY; PEPSINOGEN A; PEPSINOGEN C; PREVALENCE; QUESTIONNAIRES; SEROLOGIC TESTS;

EID: 77953778252     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04334.x     Document Type: Article

References (36)

1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005 54 : 710 717.
2. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006 354 : 2340 2348.
3. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005 143 : 199 211.
4. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol 2006 101 : 2619 2628. (Pubitemid 44665262)
5. Friedenberg FK, Xanthopoulos M, Foster GD, Richter JE. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol 2008 103 : 2111 2122.
6. El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci 2008 53 : 2307 2312.
7. O'Brien TF Jr. Lower esophageal sphincter pressure (LESP) and esophageal function in obese humans. J Clin Gastroenterol 1980 2 : 145 148.
8. Orlando RC. Overview of the mechanisms of gastroesophageal reflux. Am J Med 2001 111 (Suppl 8A 174S 7S.
9. Barak N, Ehrenpreis ED, Harrison JR, Sitrin MD. Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations. Obes Rev 2002 3 : 9 15.
10. Weck MN, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 2006 15 : 1083 1094.
11. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975 2 : 58 60.
12. El-Zimaity H. Gastritis and gastric atrophy. Curr Opin Gastroenterol 2008 24 : 682 686.
13. Rugge M, DE Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010 31 : 1104 1111.
14. Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther 2010 31 : 1042 1050.
15. Fujiwara Y, Higuchi K, Shiba M, et al. Association between gastroesophageal flap valve, reflux esophagitis, Barrett's epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J Gastroenterol 2003 38 : 533 539.
16. Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 1999 94 : 3468 3472.
17. Yamaji Y, Mitsushima T, Ikuma H, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 2001 49 : 335 340.
18. Brenner H, Rothenbacher D, Weck MN. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer 2007 121 : 2782 2786.
19. Low M, Stegmaier C, Ziegler H, Rothenbacher D, Brenner H. Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population (ESTHER study). Dtsch Med Wochenschr 2004 129 : 2643 2647.
20. Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther 2007 26 : 879 887.
21. Dore MP, Maragkoudakis E, Fraley K, et al. Diet, lifestyle and gender in gastro-esophageal reflux disease. Dig Dis Sci 2008 53 : 2027 2032.
22. Watanabe Y, Fujiwara Y, Shiba M, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol 2003 38 : 807 811.
23. Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux - a population-based study. Aliment Pharmacol Ther 2006 23 : 169 174.
24. Moayyedi P. The epidemiology of obesity and gastrointestinal and other diseases: an overview. Dig Dis Sci 2008 53 : 2293 2299.
25. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003 290 : 66 72.
26. Nilsson M, Lundegardh G, Carling L, Ye W, Lagergren J. Body mass and reflux oesophagitis: an oestrogen-dependent association? Scand J Gastroenterol 2002 37 : 626 630.
27. Sise A, Friedenberg FK. A comprehensive review of gastroesophageal reflux disease and obesity. Obes Rev 2008 9 : 194 203.
28. Sipponen P, Helske T, Jarvinen P, Hyvarinen H, Seppala K, Siurala M. Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992. Gut 1994 35 : 1167 1171.
29. de Vries AC, Meijer GA, Looman CW, et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007 56 : 1665 1670.
30. Murray L, Johnston B, Lane A, et al. Relationship between body mass and gastro-oesophageal reflux symptoms: the Bristol Helicobacter Project. Int J Epidemiol 2003 32 : 645 650.
31. Nandurkar S, Locke GR, 3rd., Fett S, Zinsmeister AR, Cameron AJ, Talley NJ. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther 2004 20 : 497 505.
32. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach Arch Intern Med 2006 166 : 965 971.
33. Festi D, Scaioli E, Baldi F, et al. Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol 2009 15 : 1690 1701.
34. Lodato F, Azzaroli F, Turco L, et al. Adverse effects of proton pump inhibitors. Best Pract Res Clin Gastroenterol 2010 24 : 193 201.
35. Storskrubb T, Aro P, Ronkainen J, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 2008 43 : 1448 1455.
36. Weck MN, Brenner H. Association of Helicobacter pylori infection with chronic atrophic gastritis: meta-analyses according to type of disease definition. Int J Cancer 2008 123 : 874 881.